Our Focus

Our challenge is to understand why breast cancer recurrences happen and to ensure that metastatic disease is detected early and treated effectively. The ability of a tumour to alter its status following treatment is clinically accepted and our team is working to identify gene determinants that can be used as biomarkers in helping to improve patient treatment strategies and ultimately develop novel drug targets helping to defeat breast cancer.